Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
D000469:Alkaline Phosphatase / Q000097:blood; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001856:Bone Marrow Examination; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D002784:Cholesterol / Q000097:blood; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects*; D009325:Nausea / Q000139:chemically induced; D010179:Pancreas / Q000187:drug effects; D010195:Pancreatitis / Q000139:chemically induced*; D012709:Serum Albumin / Q000032:analysis; D014280:Triglycerides / Q000097:blood; D014839:Vomiting / Q000139:chemically induced
D012709:Serum Albumin; D014280:Triglycerides; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001215:Asparaginase